Is Collagenase Clostridium Histolyticum-aaes Effective for Thigh Cellulite?
CCH-aaes found to be effective and well tolerated for thigh cellulite, with reduction seen in patient-reported bother due to cellulite
By Dermsquared Editorial Team | | February 08, 2023
Morphea Activity Measure Reliable, Valid for Disease Activity
Moderately strong correlations seen between MAM and modified Localized Scleroderma Severity Index, Physician Global Assessment of Activity
By Dermsquared Editorial Team | | February 08, 2023
Measles Outbreak in Ohio Declared Over After 85 Cases
Outbreak declared finished with no new cases after a period of 42 days, or the equivalent of two measles virus incubation periods
By Physician's Briefing Staff | | February 06, 2023
Is Dupilumab Beneficial for Treatment of Erythrodermic Atopic Dermatitis?
Significant improvements reported in percentage BSA affected by AD, Eczema Area and Severity Index score, Peak Pruritus Numerical Rating Scale score
By Dermsquared Editorial Team | | February 01, 2023
Local Recurrence Rate Low With Mohs for Invasive Head, Neck Melanoma
Disease-specific survival was 96.8 and 93.4 percent at five and 10 years, respectively
By Dermsquared Editorial Team | | February 01, 2023
CDC Reports on Prevalence of Seasonal and Food Allergies, Eczema
18.9 percent of children and 25.7 percent of adults had seasonal allergy; 10.8 and 7.3 percent had eczema in 2021
By Elana Gotkine (HealthDay News) | | January 26, 2023
What Is the Prevalence of Depression, Anxiety Disorders in Alopecia Areata Patients?
Prevalence of depression disorder 9 percent, anxiety disorder 7 to 17 percent; prevalence of disorders lower than depression and anxiety symptom prevalence
By Dermsquared Editorial Team | | January 25, 2023
Guidelines Issued for Gene Expression Profiling in Cutaneous Melanoma
GEP results can improve prognostic assessment for patients with tumors with uncertainty about adequacy of microstaging
By Dermsquared Editorial Team | | January 25, 2023
Risk for Subsequent Facial Keratinocyte Carcinoma Lower With Laser Treatment
Nonablative fractional laser-treated patients had lower rate of subsequent facial keratinocyte carcinoma development
By Elana Gotkine (HealthDay News) | | January 24, 2023
Air Pollution Tied to Psoriasis Occurrence
Females, children more sensitive to changes in air pollutants
By Lori Solomon (HealthDay News) | | January 23, 2023
Health Concepts From PROMs Can Be Classified Into Five Domains for Psoriasis
Most frequently captured domains are social well-being and psychological well-being; no PROM captured all five domains
By Elana Gotkine (HealthDay News) | | January 23, 2023
Guidelines Updated for Topical Treatment of Atopic Dermatitis in Adults
Strong recommendations include use of moisturizers, topical corticosteroids, topical calcineurin inhibitors
By Dermsquared Editorial Team | | January 18, 2023
Rates of Clinic Visits for Psoriasis Increased for Adults After Wildfires
Air pollution from wildfire linked to modestly increased rates of clinic visits for psoriasis among adults starting five weeks after fire
By Dermsquared Editorial Team | | January 18, 2023
MPATH-Dx Version 2.0 Simplifies Classification of Melanoma
Updated version simplifies original five-class hierarchy into four classes, including clearly defining classes I and II lesions
By Elana Gotkine (HealthDay News) | | January 13, 2023
Do Outcomes Improve With Lebrikizumab in Atopic Dermatitis?
Improvement seen in IGA(0,1) and in EASI-75 with lebrikizumab plus topical corticosteroids versus placebo plus topical corticosteroids
By Dermsquared Editorial Team | | January 11, 2023
Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis
Long-term benefits seen in patients with inadequate response/intolerance to biologic or conventional disease-modifying antirheumatic drugs
By Lori Solomon (HealthDay News) | | January 11, 2023
Survival Rates High for Children, Teens With Melanoma
Primary tumor ulceration, head/neck location, and Breslow thickness >4 mm predict worse survival in teens
By Lori Solomon (HealthDay News) | | January 10, 2023
Is Melanoma Survival Worse for Adolescents, Young Adults Versus Older Adults
Adolescents and young adults with stage IV melanoma have worse survival than that seen for older adults in adjusted age group-specific models
By Lori Solomon (HealthDay News) | | January 10, 2023
Mpox Cases Reported in Cisgender Women
2.3 percent of all reported mpox cases were in cisgender women, 44 percent of whom were non-Hispanic Black
By Elana Gotkine (HealthDay News) | | January 05, 2023
Can Certain Factors Predict Poor Outcomes in Cutaneous Squamous Cell Carcinoma?
Risks for local recurrence, disease-specific death highest in association with tumor invasion beyond subcutaneous fat
By Dermsquared Editorial Team | | January 04, 2023
Is Risk for SARS-CoV-2 Infection Increased With Biologics in Psoriasis?
Incidence of SARS-CoV-2 infection no higher with biologics, nonbiologic systemics versus other treatments
By Dermsquared Editorial Team | | January 04, 2023
Current Depression Linked to Systemic Inflammation in Psoriasis
Correlation of PHQ-2 scores with neutrophil count greater and significant only for women
By Elana Gotkine (HealthDay News) | | January 04, 2023
~10 Percent of Psoriasis Patients Have High Risk for Liver Fibrosis
Increased odds ratios seen for advanced liver fibrosis with age older than 50 years, BMI >30, diabetes, hypertension, dyslipidemia, metabolic syndrome
By Elana Gotkine (HealthDay News) | | January 04, 2023
24 of 1244
Headline from the Week of April 13 - 19, 2026
News Alert: Deucravacitinib Approved for Psoriatic Arthritis
By Dermsquared Editorial Team | | April 17, 2026
What It Means to Treat Something That Doesn’t Behave Consistently